3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
21
Lung Neoplasms
12
Prostatic Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Stomach Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
4
Breast Neoplasms
4
Neoplasms
3
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Tongue Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Interventions
zimberelimab
1
quemliclustat
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Non-Small Cell Lung Cancer
×
Docetaxel
×
30 days
×
Clear all
NCT05676931
2026-06-01
EDGE-Lung
Gilead Sciences
Phase 2
Active not recruiting
400 enrolled